« Back
Home /
Tibulizumab (IL17A/TNFSF13B/CD257) Antibody, Monoclonal

Tibulizumab (IL17A/TNFSF13B/CD257) Antibody, Monoclonal

Item no.	PRS-10-867-0.1mg
Manufacturer	ProSci
Amount	0.1 mg
Category	Neuroscience Neuroinflammation Antibodies Cell Biology Cell Culture Cytokines Primary Antibodies
Type	Antibody Monoclonal
Specific against	other
Isotype	IgG4 Kappa, scFv
Conjugate/Tag	Unconjugated
ECLASS 10.1	42030590
ECLASS 11.0	42030590
UNSPSC	12352203
Alias	LY 3090106,LY-3090106,LY3090106
Available
Manufacturer - Isotype	IgG4-kappa-[scFv]2
Shipping Temperature	blue ice or room temperature
Storage Conditions	Store at -80°C
Manufacturer - Research Area	Drug Analogues
Background	Tibulizumab is a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease.
Purification	>95%
Buffer	PBS buffer pH7.5
Immunogen	Humanized / IL17A/TNFSF13B/CD257 [Homo sapiens]
Clonality	Monoclonal
NCBI Organism	homo sapiens
Disclaimer	Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 0.1 mg

available

Delivery expected until 9/4/2025

Express Delivery: Save 24 days

Compare

Add to wishlist

Get an offer